Novo Nordisk A S
NVONYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NONOF
Financials through fiscal 2025, year ended Dec 31, 2025Score 4/30
$37.82−1.05 (-2.70%)
Close on Nov 20, 2026Market cap $168.87BP/E 11.1Yield –
Novo Nordisk A S Parent Company by Year
Parent Company — Sales and distribution costs (DKKm)
Novo Nordisk A S Parent Company: 49,129.00 DKKm in FY2025, up 0.4% from a year earlier.
Latest, FY2025
49,129.00
Period ended Dec 31, 2025
Change on a year earlier
+0.4%
48,921.00 in FY2024
History
7 years
Since FY2019
Sources
6
Documents cited below
Where the FY2025 figure comes from
“|| Sales and distribution costs | 3 | (49,129) | (48,921)”
Source: Form 20-F (filed 2026-02-04) ↗
annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Parent Company — Sales and distribution costs (DKKm) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 49,129.00 | +0.4% | Form 20-F (filed 2026-02-04) ↗ |
| FY2024 | Dec 31, 2024 | 48,921.00 | +15.7% | Form 20-F (filed 2026-02-04) ↗ |
| FY2023 | Dec 31, 2023 | 42,291.00 | +12.8% | Form 20-F (filed 2025-02-05) ↗ |
| FY2022 | Dec 31, 2022 | 37,476.00 | +24.8% | Form 20-F (filed 2024-01-31) ↗ |
| FY2021 | Dec 31, 2021 | 30,021.00 | +12.6% | Form 20-F (filed 2023-02-01) ↗ |
| FY2020 | Dec 31, 2020 | 26,673.00 | +12.9% | Form 20-F (filed 2022-02-02) ↗ |
| FY2019 | Dec 31, 2019 | 23,619.00 | – | Form 6-K (filed 2021-02-03) ↗ |
Cite this data
StockData. (2026). Novo Nordisk A S Parent Company, annual FY2019–FY2025 [Data set]. Compiled from Novo Nordisk A S SEC filings and investor materials. https://stockdatahq.com/stocks/nvo/kpis/parent-sd-costs
See every metric in the Novo Nordisk A S KPI table. Data updated Nov 3, 2026.
See a number that looks wrong?